Bibliography
- Liu J , QiuZ, WangS, ZhouL, ZhangS. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomedical Materials5(6), 065002 (2010).
- Mora-Huertas CE , FessiH, ElaissariA. Polymer-based nanocapsules for drug delivery. Int. J. Pharm.385(1–2), 113–142 (2010).
- Qian F , CuiF, DingJet al. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization. Biomacromolecules 7(10), 2722–2727 (2006).
- Wang T , WangN, ZhangYet al. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles. Colloids Surf. B Biointerfaces. 79(1), 254–261 (2010).
- Hong Y , HuFQ, YuanH. Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles. Pharmazie61(4), 312–315 (2006).
- Uner M , YenerG. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine2(3), 289–300 (2007).
- Wissing SA , KayserO, MüllerRH. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev.56(9), 1257–1272 (2004).
- Li Z , LiX, ZhengLet al. Bovine serum albumin loaded solid lipid nanoparticles prepared by double emulsion method. Chem. Res. Chinese Universities 26(1), 136–141 (2010).
- Trickler WJ , KhuranaJ, NagvekarAAet al. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. AAPS PharmSciTech 11(1), 392–401 (2010).
- Goycoolea FM , LolloG, Remunan-LopezCet al. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules 10(7), 1736–1743 (2009).
- Sarmento B , RibeiroA, VeigaFet al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24(12), 2198–2206 (2007).
- Rudzinski WE , AminabhaviTM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm.399(1–2), 1–11 (2010).
- Bhumkar DR , PokharkarVB. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech7(2), E50 (2006).
- Nasti A , ZakiNM, de Leonardis P et al. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm. Res.26(8), 1918–1930 (2009).
- Wu Y , YangW, WangCet al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. 295 (1–2), 235–245 (2005).
- Bowman K , LeongKW. Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomedicine1(2), 117–128 (2006).
- Oliveira BF , SantanaMHA, RéMI. Spray-dried chitosan microspheres cross-linked with D, L-glyceraldehyde as a potential drug delivery system: preparation and characterization. Brazil. J. Chem. Eng.22(3), 353–360 (2005).
- Gupta KC , JabrailFH. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman. Carbohydr. Res.341(6), 744–756 (2006).
- Anal AK , StevensWF, Remuñán-LópezC. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int. J. Pharm.312(1–2), 166–173 (2006).
- Xu Y , HannaMA. Electrosprayed bovine serum albumin-loaded tripolyphosphate cross-linked chitosan capsules: synthesis and characterization. J. Microencapsul.24(2), 143–151 (2007).
- Csaba N , Koping-HoggardM, Fernandez-MegiaEet al. Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 5(2), 162–171 (2009).
- Trickler WJ , NagvekarAA, DashAK. The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel. Pharm. Res.26(8), 1963–1973 (2009).
- Popescu G , BarauskasJ, NylanderTet al. Liquid crystalline phases and their dispersions in aqueous mixtures of glycerol monooleate and glyceryl monooleyl ether. Langmuir 23(2), 496–503 (2007).
- Bei D , MarszalekJ, YouanBB. Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. AAPS PharmSciTech (3), 1032–1039 (2009).
- Efrat R , KesselmanE, AserinAet al. Solubilization of hydrophobic guest molecules in the monoolein discontinuous QL cubic mesophase and its soft nanoparticles. Langmuir 25(3), 1316–1326 (2009).
- Kumar MK , ShahMH, KetkarAet al. Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int. J. Pharm. 272 (1–2), 151–160 (2004).
- Trickler WJ , NagvekarAA, DashAK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech9(2), 486–493 (2008).
- Zhang J , TianQ, ZhouS. Clinical pharmacology of cyclophosphamide and ifosfamide. Curr. Drug Ther.1(1), 55–84 (2006).
- Aleksa K , Nava-OcampoA, KorenG. Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS. Chirality21(7), 674–680 (2009).
- Sottani C , RinaldiP, LeoniEet al. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation. Rapid Commun. Mass Spectrom. 22(17), 2645–2659 (2008).
- Mufioz M , BonjochJ, PratJet al. Degradation kinetics of ifosfamide in aqueous solution. Int. J. Pharm. 139 (1–2), 249–253 (1996).
- Gilard V , MartinoR, Malet-MartinoMet al. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions. J. Med. Chem. 42(14), 2542–2560 (1999).
- Lin Y , SonajeK, LinKMet al. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J. Controll. Release 132(2), 141–149 (2008).
- Boyd BJ , WhittakerDV, KhooSet al. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309 (1–2), 218–226 (2006).
- Binks BP , LumsdonSO. Catastrophic phase inversion of water-in-oil emulsions stabilized by hydrophobic silica. Langmuir16(6), 2539–2547 (2000).
- Oba N , SugimuraH, UmeharaYet al. Evaluation of an oleic acid water-in-oil-in-water-type multiple emulsion as potential drug carrier via the enteral route. Lipids 27(9), 701–705 (1992).
- Mu L , FengSS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J. Control. Release80(1–3), 129–144 (2002).
- Sannan T , KuritaK, IwakuraY. Studies on chitin, 2. Effect of deacetylation on solubility. Die Makromolekulare Chemie177(12), 3589–3600 (1976).
- Gaumet M , GurnyR, DelieF. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur. J. Pharm. Sci.36(4–5), 465–473 (2009).
- Peltonen L , AittaJ, HyvonenSet al. Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(L)lactide nanoparticles. AAPS PharmSciTech 5(1), E16 (2004).
- Zhang H , WuS, TaoYet al. Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J. Nanomaterials 2010, 1–1 (2010).
- Kumar V , Prud‘hommeRK. Thermodynamic limits on drug loading in nanoparticle cores. J. Pharm. Sci.97(11), 4904–4914 (2008).
- Tang X , PikalMJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm. Res.21(2), 191–200 (2004).
- Takashima Y , SaitoR, NakajimaAet al. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres. Int. J. Pharm. 343 (1–2), 262–269 (2007).
- Date PV , SamadA, DevarajanPV. Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech11(1), 304–313 (2010).
- De S , RobinsonDH. Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy. AAPS PharmSciTech5(4), E53 (2004).
- Jennings T . Lyophilization – Introduction and Basic Principles. Informa Healthcare, New York, London (1999).
- Shu XZ , ZhuKJ. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm.54(2), 235–243 (2002).
- Dash AK , MillerDW, Huai-YanHet al. Evaluation of creatine transport using Caco-2 monolayers as an in vitro model for intestinal absorption. J. Pharm. Sci. 90(10), 1593–1598 (2001).
- Yee S . In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man – fact or myth. Pharm. Res.14(6), 763–766 (1997).
- Schwartz CL , GorlickR, TeotLet al. Multiple drug resistance in osteogenic sarcoma: int0133 from the children‘s oncology group. J. Clin. Oncol. 25(15), 2057–2062 (2007).
- Rejman J , OberleV, ZuhornISet al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (Pt 1), 159–169 (2004).
- Chavanpatil MD , KhdairA, PanyamJ. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J. Nanosci. Nanotechnol.6(9–10), 2651–2663 (2006).